Free Trial
NASDAQ:BCPC

Balchem (BCPC) Stock Price, News & Analysis

Balchem logo
$165.49 -1.02 (-0.61%)
(As of 12/20/2024 05:15 PM ET)

About Balchem Stock (NASDAQ:BCPC)

Key Stats

Today's Range
$163.94
$167.37
50-Day Range
$165.49
$183.41
52-Week Range
$135.84
$186.03
Volume
571,223 shs
Average Volume
113,001 shs
Market Capitalization
$5.38 billion
P/E Ratio
44.49
Dividend Yield
0.53%
Price Target
$190.00
Consensus Rating
Buy

Company Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Balchem Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
93rd Percentile Overall Score

BCPC MarketRank™: 

Balchem scored higher than 93% of companies evaluated by MarketBeat, and ranked 28th out of 193 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Balchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Balchem has only been the subject of 1 research reports in the past 90 days.

  • Read more about Balchem's stock forecast and price target.
  • Earnings Growth

    Earnings for Balchem are expected to grow by 10.74% in the coming year, from $4.19 to $4.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Balchem is 44.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.72.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Balchem is 44.49, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 111.90.

  • Price to Earnings Growth Ratio

    Balchem has a PEG Ratio of 5.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Balchem has a P/B Ratio of 5.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.35% of the float of Balchem has been sold short.
  • Short Interest Ratio / Days to Cover

    Balchem has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Balchem has recently decreased by 10.95%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Balchem has a dividend yield of 0.23%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Balchem has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Balchem is 23.39%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Balchem will have a dividend payout ratio of 18.75% next year. This indicates that Balchem will be able to sustain or increase its dividend.

  • Read more about Balchem's dividend.
  • Percentage of Shares Shorted

    1.35% of the float of Balchem has been sold short.
  • Short Interest Ratio / Days to Cover

    Balchem has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Balchem has recently decreased by 10.95%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Balchem has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Balchem this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for BCPC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Balchem to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Balchem insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.25% of the stock of Balchem is held by insiders.

  • Percentage Held by Institutions

    87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Balchem's insider trading history.
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Stock News Headlines

Balchem Increases Annual Dividend by 10.1%
How Low-Cost Stocks Generate Monthly Income
Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!
Balchem Raises Annual Dividend by 10%
Balchem Corporation Announces Dividend
Balchem Corp.
See More Headlines

BCPC Stock Analysis - Frequently Asked Questions

Balchem's stock was trading at $148.75 at the start of the year. Since then, BCPC shares have increased by 11.3% and is now trading at $165.49.
View the best growth stocks for 2024 here
.

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings data on Friday, February, 16th. The basic materials company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.02. The business's revenue for the quarter was down 1.6% compared to the same quarter last year.

Balchem subsidiaries include Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and others.

Balchem's top institutional shareholders include Wasatch Advisors LP (4.17%), State Street Corp (3.80%), Conestoga Capital Advisors LLC (3.63%) and Geode Capital Management LLC (2.86%). Insiders that own company stock include Theodore L Harris, David B Fischer, Gunsteren Job Leonard Van, William A Backus and Michael Robert Sestrick.
View institutional ownership trends
.

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
2/16/2024
Today
12/20/2024
Ex-Dividend for 1/17 Dividend
12/26/2024
Fiscal Year End
12/31/2024
Dividend Payable
1/17/2025

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CUSIP
05766520
CIK
9326
Employees
1,302
Year Founded
1967

Price Target and Rating

Average Stock Price Target
$190.00
High Stock Price Target
$190.00
Low Stock Price Target
$190.00
Potential Upside/Downside
+14.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$108.54 million
Pretax Margin
16.47%

Debt

Sales & Book Value

Annual Sales
$942.38 million
Cash Flow
$4.71 per share
Book Value
$32.69 per share

Miscellaneous

Free Float
32,102,000
Market Cap
$5.38 billion
Optionable
Optionable
Beta
0.67

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:BCPC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners